Searched for
ANTIBIOTICS
Pharma in her DNA, Wockhardt scion ready for deep dive in the USZahabiya Khorakiwala is leading Wockhardt's US business and the launch of its new antibiotic, Zaynich. This drug targets resistant bacteria...- Shigella scare in Kerala: Check symptoms, treatment and causes of the infection that killed 4-year-old in KozhikodeShigella Spreading in Kerala? Kerala has intensified surveillance and testing following its first reported Shigella-related death of a four...
- When Malayalam superstar Mammootty threw Salim Kumar's shoes into a river during US trip: What happened next left the actor stunnedMalayalam cinema mourns the loss of veteran actor Salim Kumar. He passed away at 56 after a cardiac arrest. Tributes pour in, including an ...
- Salim Kumar cause of death: National Award-winning Malayalam actor dies at 56. His last Instagram post goes viralMalayalam cinema mourns the loss of National Award-winning actor Salim Kumar, who passed away at 56 after battling a liver-related illness....
- India’s rising export champion faces a critical credibility testIndia's seafood exports are soaring, reaching record highs and aiming for $30 billion within five years. Despite overcoming US tariffs and ...
- Banned substance in shrimp: Vet shops under close watchIndia's top drug regulator is cracking down on veterinary shops. This action follows a significant rejection of shrimp exports to major mar...
- FirstClub raises $55 million from Peak XV, Sofina; valuation doubles to $255 millionQuality-focused grocery delivery startup FirstClub has secured $55 million in a Series B funding round led by Peak XV Partners and Sofina, ...
- Metals rally largely priced in, limited upside seen after strong cyclical run: Sandip SabharwalMarket expert Sandip Sabharwal advises caution, seeing stock-specific chances but limited broad market conviction. He notes Wockhardt's app...
- Wockhardt shares pause massive 36% rally in 5 sessions; slip 7%. What’s behind the selloff?Wockhardt shares dropped after a recent surge, as investors took profits. This followed the US FDA approval of ZAYNICH, an antibiotic for u...
- Zaynich's blockbuster potential lifts Wockhardt's long-term outlookWockhardt's novel antibiotic, Zaynich, has received USFDA approval after a 12-year effort, sparking hopes for a turnaround after years of n...
- Delhi HC allows Intas to sell cancer drug Bevatas, sets aside order favouring Sun PharmaThe Delhi High Court division bench has ruled in favor of Intas Pharmaceuticals, allowing the company to introduce its anti-cancer medicati...
- If you have the patience, you can achieve innovation milestones, says Wockhardt chairman Habil KhorakiwalaWockhardt Hospitals is set to launch its antibiotic Zaynich in the US. Zahabiya Khorakiwala will lead US operations. The drug is expected t...
- Good news for diabetes & BP patients: Govt cuts prices of these 30 medicines, relief may reach pharmacies soonThe National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 30 essential drug formulations, including those for diabet...
- Aegis Logistics shares rally 4% as Q4 profit rises 45% YoY; Board recommends dividendAegis Logistics shares rose sharply after the company reported a 45% year-on-year rise in Q4 FY26 consolidated net profit to Rs 413 crore, ...
- Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check detailsWockhardt's shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections....
- FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics marketWockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...
- Novartis experimental actinium-based drug shows promise in prostate cancer treatment: StudyNovartis' new experimental actinium-based drug shows promise against prostate cancer. Early data on Sunday revealed anti-tumour activity, e...
- Wockhardt secures US FDA approval for antibiotic ZaynichWockhardt's novel antibiotic, Zaynich (cefepime and zidebactam), has received US FDA approval for complicated urinary tract infections. Thi...
- Wockhardt shares jump 8%, extend rally after CDSCO nod for Zaynich antibioticWockhardt shares surged after the company received CDSCO approval for its breakthrough antibiotic Zaynich in India. Strong Phase 3 trial re...
- Wockhardt gets CDSCO nod for Zaynich antibioticWockhardt Ltd has secured approval from the CDSCO for its new antibiotic, Zaynich. This drug is developed in India and will be used to trea...
Load More
